{"id":"antiwei-granules","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Antiwei Granules is a Chinese herbal medicine preparation developed by Tasly Pharmaceutical Group. It is designed to enhance immune function and reduce inflammation through multiple botanical components. The formulation is being investigated in Phase 3 trials, likely for cancer-related indications based on its immunomodulatory properties.","oneSentence":"Antiwei Granules is a traditional Chinese medicine formulation that modulates immune function and inflammatory pathways to support anti-tumor activity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:03.066Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer-related conditions (specific indication not publicly detailed)"}]},"trialDetails":[{"nctId":"NCT06697886","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2023-11-16","conditions":"Common Cold","enrollment":480}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Antiwei Granules","genericName":"Antiwei Granules","companyName":"Tasly Pharmaceutical Group Co., Ltd","companyId":"tasly-pharmaceutical-group-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antiwei Granules are a small molecule treatment for the common cold, specifically for wind-cold syndrome. They are being studied in a clinical trial (NCT06697886) to evaluate their efficacy and safety in treating this condition.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}